Click here for Analysts' Upgrades, Downgrades.
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
estimates, target raised at Goldman. Shares of AA now seen reaching $14, according to Goldman Sachs. Estimates also increased, to reflect higher aluminum prices. Neutral rating.
price target increased at Barclays to $9 from $6. Increased global demand for their electronic devices and products, Barclays said. Maintain Equal Weight rating.
estimates, target lowered at UBS. Shares of ATHN now seen reaching $26, according to UBS. Estimates also cut, as the company is investing more in future growth. Sell rating.
estimates, target boosted at Citigroup. Shares of ATU now seen reaching $29, according to Citigroup. Estimates also upped, to match the company's new guidance. Hold rating.
estimates, target boosted at Goldman. Shares of CNC now seen reaching $28, according to Goldman Sachs. Estimates also upped, to match the company's new guidance. Buy rating.
price target raised at Credit Suisse to $115 from $111. Disappointing 2Q11 results but we remain bullish given global economic growth is accelerating, Credit Suisse said. Maintain Outperform rating.
estimates, target boosted at Goldman. Shares of FDX now seen reaching $105, according to Goldman Sachs. Estimates also upped, given better domestic volume and pricing. Neutral rating.
numbers increased at Goldman. GPC estimates were raised through 2012. Company continues to see strong industrial and automotive demand. Neutral rating and new $54 price target.
price target raised at Barclays to $66 from $44. Semiconductor test industry is picking up, Barclays said. Maintain Overweight rating.
( RIMM) price target higher at Barclays. NVLS price target increased to $36 from $31. Novellus is the clear winner in underappreciated companies that offer Alpha, Barclays said. Maintain Equal Weight rating.
Research in Motion Limited
( RIMM) price target higher at Credit to $85 from $75 on strong results and superb execution, Credit Suisse said. 2011 and 2012 EPS estimates raised to $6.29 and $7.33, respectively. Maintain Outperform rating.
Research in Motion
( RIMM) numbers raised at Goldman. Shares of RIMM now seen reaching $60, according to Goldman Sachs. Estimates also increased, as the company is seeing higher sales. Sell rating.
estimates cut at UBS through 2011, UBS said. Company is guiding toward lower production rates. Buy rating and $42 price target.
cut from Conviction Buy List at Goldman. $93 price target. Regulatory issues will likely continue to hang over the stock.
This article was written by a staff member of TheStreet.